跳至主要内容
临床试验/CTRI/2020/05/025329
CTRI/2020/05/025329尚未招募3 期

Prophylactic extended field versus pelvic only intensity modulated radiotherapy with concurrent chemotherapy in locally advanced carcinoma cervix: a prospective randomized study

AIIMS New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Biopsy proven carcinoma of cervix (squamous, adenocarcinoma or adenosquamous carcinoma)
  • 2.FIGO stage IB3 â?? IIIC1 (FIGO 201816)
  • 3.Negative paraortic nodes on baseline PET/CT
  • 4.Age 18-65 years
  • 5.Karnofsky performance scale > 70
  • 6.Normal Hemogram:
  • a.Hemoglobin >= 10mg/dl
  • b.Total Leukocyte count >= 4,000 cells/mm3
  • c.Absolute neutrophil count >= 1500 cells/mm3
  • d.Platelet count >= 100000 cells/mm3
  • 7.Normal liver and kidney function tests
  • 8.Negative pregnancy test for women of child bearing potential
  • 9.Ready to sign informed consent prior to study entry

排除标准

  • 1.Any previous malignancy
  • 2.Those who received radiotherapy and/or chemotherapy or underwent pelvic surgery
  • 3.Pregnant and lactating patients
  • 4.Deranged Hemogram, LFT and KFT
  • 5.Positive paraaortic lymph nodes on baseline PET/CT
  • 6.Patients refusing to give written informed consent
  • 7.Uncontrolled diabetes, hypertension
  • 8.Any other co-morbidity hampering radical treatment of cervical cancer

研究者

发起方
AIIMS New Delhi

相似试验